Clinical Endoscopy

The Korean Society of Gastrointestinal Endoscopy (대한소화기내시경학회)
권호 표지
DOI QR코드

DOI QR Code

Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial

  • Satimai Aniwan (Gastrointestinal Endoscopy Excellence Center, Division of Gastroenterology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital)
  • Received : 2022.01.30
  • Accepted : 2022.02.06
  • Published : 2022.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Ran Z, Wu K, Matsuoka K, et al. Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia. J Gastroenterol Hepatol 2021;36:637-645.
  2. Jin XJ, Kim JM, Kim HK, et al. Histopathology and TB-PCR kit analysis in differentiating the diagnosis of intestinal tuberculosis and Crohn's disease. World J Gastroenterol 2010;16:2496-2503.
  3. Lu Y, Chen Y, Peng X, et al. Development and validation of a new algorithm model for differential diagnosis between Crohn's disease and intestinal tuberculosis: a combination of laboratory, imaging and endoscopic characteristics. BMC Gastroenterol 2021;21:291.
  4. Limsrivilai J, Shreiner AB, Pongpaibul A, et al. Meta-analytic Bayesian model for differentiating intestinal tuberculosis from crohn's disease. Am J Gastroenterol 2017;112:415-427.
  5. Xu H, Li Y, Qian JM. A meta-analysis of the accuracy of interferon-γ release assays in differentiating intestinal tuberculosis from Crohn's disease in Asia. Zhonghua Nei Ke Za Zhi 2016;55:535-540.
  6. Zhao Y, Xu M, Chen L, Liu Z, Sun X. Levels of TB-IGRA may help to differentiate between intestinal tuberculosis and Crohn's disease in patients with positive results. Therap Adv Gastroenterol 2020;13:1756284820922003.
  7. Limsrivilai J, Pausawasdi N. Intestinal tuberculosis or Crohn's disease: a review of the diagnostic models designed to differentiate between these two gastrointestinal diseases. Intest Res 2021;19:21-32.
  8. Limsrivilai J, Lee CK, Prueksapanich P, et al. Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn's disease: a multicenter study from Asia. PLoS One 2020;15:e0242879.
  9. Jo HH, Kim EY, Jung JT, et al. Value of fecal calprotectin measurement during the initial period of therapeutic anti-tubercular trial. Clin Endosc 2022;55:256-262.
  10. Sharma V, Verma S, Kumar MP, et al. Serial measurements of faecal calprotectin may discriminate intestinal tuberculosis and Crohn's disease in patients started on antitubercular therapy. Eur J Gastroenterol Hepatol 2021;33:334-338.